Enveric Biosciences, Inc. (ENVB)
CIK 890821 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Enveric Biosciences, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Aug 14, 2026 | 10-Q | 0001493152-26-038418 |
| Aug 14, 2026 | 8-K | 0001493152-26-038385 |
| Aug 14, 2026 | SCHEDULE 13G | 0001172661-26-003572 |
| Aug 14, 2026 | SCHEDULE 13G/A | 0000929638-26-003073 |
| Aug 13, 2026 | SCHEDULE 13G/A | 0001493152-26-037652 |
| Jun 9, 2026 | 8-K | 0001493152-26-027781 |
| Jun 9, 2026 | 8-K | 0001493152-26-027976 |
| Jun 9, 2026 | 424B5 | 0001493152-26-027975 |
| Jun 3, 2026 | 4 | 0001761753-26-000003 |
| Jun 3, 2026 | 4 | 0001597334-26-000002 |
| Jun 3, 2026 | 4 | 0001645282-26-000002 |
| Jun 3, 2026 | 4 | 0002025032-26-000002 |
| Jun 3, 2026 | 4 | 0001883914-26-000003 |
| Jun 3, 2026 | 4 | 0001883966-26-000003 |
| Jun 3, 2026 | 4 | 0001239463-26-000002 |
| Jun 3, 2026 | 4 | 0001967056-26-000003 |
| Jun 1, 2026 | S-8 | 0001493152-26-026476 |
| May 29, 2026 | 8-K | 0001493152-26-026364 |
| May 15, 2026 | 10-Q | 0001493152-26-023353 |
| May 15, 2026 | 8-K | 0001493152-26-023345 |
| May 15, 2026 | SCHEDULE 13G/A | 0000929638-26-001905 |
| May 4, 2026 | D | 0000890821-26-000002 |
| Apr 30, 2026 | 8-K | 0001493152-26-020410 |
| Apr 30, 2026 | DEFA14A | 0001493152-26-020405 |
| Apr 29, 2026 | 424B3 | 0001493152-26-019676 |